Global Cardiopulmonary Bypass Equipment Market Size, Share: By Product: Heart–Lung Machines, Oxygenators, Autotransfusion Systems, Others; By Application: Cardiovascular, Respiratory, Hemodialysis, Others; By Type: Single Roller Pump, Double Roller Pump; By End User: Hospitals, Others; Regional Analysis; Supplier Landscape; 2024-2032

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Global Cardiopulmonary Bypass Equipment Market Overview 
    3.1    Global Cardiopulmonary Bypass Equipment Market Historical Value (2017-2023) 
    3.2    Global Cardiopulmonary Bypass Equipment Market Forecast Value (2024-2032)
4    Global Cardiopulmonary Bypass Equipment Market Landscape*
    4.1    Global Cardiopulmonary Bypass Equipment: Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Cardiopulmonary Bypass Equipment: Product Landscape
        4.2.1    Analysis by Product    
        4.2.2    Analysis by Application
5    Global Cardiopulmonary Bypass Equipment Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
        5.2.1    Strengths
        5.2.2    Weaknesses
        5.2.3    Opportunities
        5.2.4    Threats
    5.3    Porter’s Five Forces Model
        5.3.1    Bargaining Power of Suppliers
        5.3.2    Bargaining Power of Buyers
        5.3.3    Threat of New Entrants
        5.3.4    Threat of Substitutes
        5.3.5    Degree of Rivalry
    5.4    Key Demand Indicators 
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends  
    5.7    Value Chain Analysis
6    Global Cardiopulmonary Bypass Equipment Market Segmentation (2017-2032)
    6.1    Global Cardiopulmonary Bypass Equipment Market (2017-2032) by Product
        6.1.1    Market Overview
        6.1.2    Heart–Lung Machines
        6.1.3    Oxygenators
        6.1.4    Autotransfusion Systems
        6.1.5    Others
    6.2    Global Cardiopulmonary Bypass Equipment Market (2017-2032) by Application
        6.2.1    Market Overview
        6.2.2    Cardiovascular
        6.2.3    Respiratory
        6.2.4    Hemodialysis
        6.2.5    Others
    6.3    Global Cardiopulmonary Bypass Equipment Market (2017-2032) by Type
        6.3.1    Market Overview
        6.3.2    Single Roller Pump
        6.3.3    Double Roller Pump
    6.4    Global Cardiopulmonary Bypass Equipment Market (2017-2032) by End User
        6.4.1    Market Overview
        6.4.2    Hospitals
        6.4.3    Specialty Clinics
        6.4.4    Dialysis Centers
        6.4.5    Ambulatory Surgery Centers
    6.5    Global Cardiopulmonary Bypass Equipment Market (2017-2032) by Region
        6.5.1    Market Overview
        6.5.2    North America
        6.5.3    Europe 
        6.5.4    Asia Pacific
        6.5.5    Latin America
        6.5.6    Middle East and Africa
7    North America Cardiopulmonary Bypass Equipment Market (2017-2032)
    7.1    North America Cardiopulmonary Bypass Equipment Market (2017-2032) by Product
        7.1.1    Market Overview    
        7.1.2    Heart–Lung Machines
        7.1.3    Oxygenators
        7.1.4    Autotransfusion Systems
        7.1.5    Others
    7.2    North America Cardiopulmonary Bypass Equipment Market (2017-2032) by Application
        7.2.1    Market Overview
        7.2.2    Cardiovascular
        7.2.3    Respiratory
        7.2.4    Hemodialysis
        7.2.5    Others
    7.3    North America Cardiopulmonary Bypass Equipment Market (2017-2032) by Country
        7.3.1    United States of America
        7.3.2    Canada
8    Europe Cardiopulmonary Bypass Equipment Market (2017-2032)
    8.1    Europe Cardiopulmonary Bypass Equipment Market (2017-2032) by Product
        8.1.1    Market Overview    
        8.1.2    Heart–Lung Machines
        8.1.3    Oxygenators
        8.1.4    Autotransfusion Systems
        8.1.5    Others
    8.2    Europe Cardiopulmonary Bypass Equipment Market (2017-2032) by Application
        8.2.1    Market Overview
        8.2.2    Cardiovascular
        8.2.3    Respiratory
        8.2.4    Hemodialysis
        8.2.5    Others
    8.3    Europe Cardiopulmonary Bypass Equipment Market (2017-2032) by Country
        8.3.1    United Kingdom
        8.3.2    Germany
        8.3.3    France
        8.3.4    Italy
        8.3.5    Others
9    Asia Pacific Cardiopulmonary Bypass Equipment Market (2017-2032)
    9.1    Asia Pacific Cardiopulmonary Bypass Equipment Market (2017-2032) by Product
        9.1.1    Market Overview    
        9.1.2    Heart–Lung Machines
        9.1.3    Oxygenators
        9.1.4    Autotransfusion Systems
        9.1.5    Others
    9.2    Asia Pacific Cardiopulmonary Bypass Equipment Market (2017-2032) by Application
        9.2.1    Market Overview
        9.2.2    Cardiovascular
        9.2.3    Respiratory
        9.2.4    Hemodialysis
        9.2.5    Others
    9.3    Asia Pacific Cardiopulmonary Bypass Equipment Market (2017-2032) by Country
        9.3.1    China
        9.3.2    Japan
        9.3.3    India
        9.3.4    ASEAN
        9.3.5    Australia
        9.3.6    Others
10    Latin America Cardiopulmonary Bypass Equipment Market (2017-2032)
    10.1     Latin America Cardiopulmonary Bypass Equipment Market (2017-2032) by Product
        10.1.1    Market Overview    
        10.1.2    Heart–Lung Machines
        10.1.3    Oxygenators
        10.1.4    Autotransfusion Systems
        10.1.5    Others
    10.2    Latin America Cardiopulmonary Bypass Equipment Market (2017-2032) by Application
        10.2.1    Market Overview
        10.2.2    Cardiovascular
        10.2.3    Respiratory
        10.2.4    Hemodialysis
        10.2.5    Others
    10.3    Latin America Cardiopulmonary Bypass Equipment Market (2017-2032) by Country
        10.3.1    Brazil
        10.3.2    Argentina
        10.3.3    Mexico
        10.3.4    Others
11    Middle East and Africa Cardiopulmonary Bypass Equipment Market (2017-2032)
    11.1     Middle East and Africa Cardiopulmonary Bypass Equipment Market (2017-2032) by Product
        11.1.1    Market Overview    
        11.1.2    Heart–Lung Machines
        11.1.3    Oxygenators
        11.1.4    Autotransfusion Systems
        11.1.5    Others
    11.2    Middle East and Africa Cardiopulmonary Bypass Equipment Market (2017-2032) by Application
        11.2.1    Market Overview
        11.2.2    Cardiovascular
        11.2.3    Respiratory
        11.2.4    Hemodialysis
        11.2.5    Others
    11.3    Middle East and Africa Cardiopulmonary Bypass Equipment Market (2017-2032) by Country
        11.3.1    Saudi Arabia
        11.3.2    United Arab Emirates
        11.3.3    Nigeria
        11.3.4    South Africa
        11.3.5    Others
12    Regulatory Framework
    12.1     Regulatory Overview
        12.1.1    US FDA
        12.1.2    EU EMA
        12.1.3    INDIA CDSCO
        12.1.4    JAPAN PMDA
        12.1.5    Others
13    Patent Analysis
    13.1     Analysis by Type of Patent
    13.2     Analysis by Publication Year
    13.3     Analysis by Issuing Authority
    13.4     Analysis by Patent Age
    13.5     Analysis by CPC Analysis
    13.6     Analysis by Patent Valuation 
    13.7     Analysis by Key Players
14    Grants Analysis
    14.1     Analysis by Year
    14.2     Analysis by Amount Awarded
    14.3     Analysis by Issuing Authority
    14.4     Analysis by Grant Application
    14.5     Analysis by Funding Institute
    14.6     Analysis by Departments
    14.7     Analysis by Recipient Organization 
15    Funding and Investment Analysis
    15.1     Analysis by Funding Instances
    15.2     Analysis by Type of Funding
    15.3     Analysis by Funding Amount
    15.4     Analysis by Leading Players
    15.5     Analysis by Leading Investors
    15.6     Analysis by Geography
16    Partnership and Collaborations Analysis
    16.1     Analysis by Partnership Instances
    16.2     Analysis by Type of Partnership
    16.3     Analysis by Leading Players
    16.4     Analysis by Geography
17    Supplier Landscape
    17.1    Market Share by Top 5 Companies 
    17.2    Medtronic PLC
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications 
    17.3    LivaNova PLC
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    MAQUET Holding B.V. & Co. KG. 
        17.4.1    Financial Analysis
        17.4.2    Product Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    Terumo Corporation
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Braile Biomedica Ltd
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    Tianjin Medical
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    Senko Medical Instrument Manufacturing Co. Ltd.
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    Abbott 
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    Becton, Dickinson and Company 
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
    17.11    Beijing ZKSK Technology Co., Ltd. 
        17.11.1    Financial Analysis
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Mergers and Acquisitions
        17.11.5    Certifications
    17.12    Nipro Corporation
        17.12.1    Financial Analysis
        17.12.2    Product Portfolio
        17.12.3    Demographic Reach and Achievements
        17.12.4    Mergers and Acquisitions
        17.12.5    Certifications 
    17.13    MicroPort Scientific Corporation 
        17.13.1    Financial Analysis
        17.13.2    Product Portfolio
        17.13.3    Demographic Reach and Achievements
        17.13.4    Mergers and Acquisitions
        17.13.5    Certifications 
    17.14    Precision Medical, Inc. 
        17.14.1    Financial Analysis
        17.14.2    Product Portfolio
        17.14.3    Demographic Reach and Achievements
        17.14.4    Mergers and Acquisitions
        17.14.5    Certifications
    17.15    Zimmer Biomet Holdings, Inc.  
        17.15.1    Financial Analysis
        17.15.2    Product Portfolio
        17.15.3    Demographic Reach and Achievements
        17.15.4    Mergers and Acquisitions
        17.15.5    Certifications
    17.16    Technowood Corporation
        17.16.1    Financial Analysis
        17.16.2    Product Portfolio
        17.16.3    Demographic Reach and Achievements
        17.16.4    Mergers and Acquisitions
        17.16.5    Certifications 
18    Global Cardiopulmonary Bypass Equipment Market – Distribution Model (Additional Insight)
    18.1     Overview 
    18.2     Potential Distributors 
    18.3     Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company  Competitiveness Analysis (Additional Insight)
    20.1     Very Small Companies
    20.2     Small Companies
    20.3     Mid-Sized Companies
    20.4     Large Companies
    20.5     Very Large Companies
21    Payment Methods (Additional Insight)
    21.1     Government Funded
    21.2     Private Insurance
    21.3     Out-of-Pocket

*Additional insights provided are customisable as per client requirements.

* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.